glp-1 and thyroid medication No Increased Risk for Cancer in Diabetic Patients Prescribed Medications Compared to Those Prescribed Insulin Semaglutide and Thyroid Medication: Safety

Individualization is Key: The ADA strongly advocates tailoring HbA1c goals based on: Duration of diabetes Risk of hypoglycemia Life expectancy Comorbidities (cardiovascular disease, CKD) Patient preference and treatment burden Beyond HbA1c: Modern diabetes care increasingly integrates Continuous Glucose Monitoring (CGM) metrics such as Time in Range (TIR) alongside HbA1c

Dietary supplements like Kourtney Kardashians Lemme GLP-1 Daily have hit the market recently, but experts say these supplements lack the data and evidence needed to support their weight loss claims.

For Research Use Only

GLP-1 agonists may: Optimize high-risk patients before surgery Improve metabolic control Potentially reduce surgical risk But durable long-term outcomes in severe obesity still rely heavily on: Surgical intervention Lifelong follow-up Nutritional monitoring Multidisciplinary care The future may not be medicine vs surgery. It may be the intelligent integration of both

In an exclusive interview, the 43-year-old tells PEOPLE how the surgeries changed her life, and why she plans to have more.